Skip to content

Provide Point-of-Contact

Opportunity

Clinical trial participants may have many questions and concerns during and after the clinical trial. To help address participants’ questions / concerns in a timely manner, support (e.g., phone number to call, in-app support, virtual bot) can allow clinical trial participants to receive answers and reassurance without needing to wait for the next scheduled visit. 

Considerations to Help Action the Opportunity

  • Partner with investigative sites to ensure understanding of currently available site contact support and what support sites may need to enable flexibility
  • Identify multiple options for a participant to contact / stay engaged with the investigative site or reach out to a designated contact
  • Provide a clear description of which service should be used in each situation and point of contact, if several service options are available
  • Offer service(s) in the participant’s native language and make them available 24/7
  • Partner with participants / patient organizations to ensure support services are easy to use and fit their needs​
  • Provide tools and training to enable participant self service 

Value and Potential Benefits

  • Allows participants to ask questions regarding clinical trial participation when needed, potentially alleviating concerns at the current time rather than waiting for next visit
  • May increase participant engagement by allowing stronger connectivity between participants and clinical trial staff

Tools and Resources

  • No tools or resources currently available to support this opportunity

Related Blog Posts

Redesigning Clinical Trials Using Artificial Intelligence

While tech evangelists often tout artificial intelligence (AI) as healthcare’s silver bullet, the reality in clinical trials is more complex. Adoption has been cautious, shaped as much by concerns around trust and governance as by technical hurdles. Still, beneath the surface, methodical innovation is gaining momentum. AI is beginning to reshape how trials are designed,…

How Pandemic-Era Ingenuity Fuels the Future of Clinical Trials

It’s hard to believe that just five years ago, the clinical research industry found itself scrambling to adapt overnight. The COVID-19 pandemic ground global health systems to a halt and forced us all to move faster and more collaboratively than ever before. Read the full article by Allison Cuff Shimooka from The Medicine Maker here.

Science is Moving—Clinical Trials Must Catch Up

Clinical research has never been more capable of reaching new frontiers. The science is here. The technology is here. But the approach to trial design and execution hasn’t kept pace. The clinical research ecosystem proceeds cautiously for good reasons—patient safety chief among them. But too often, we’re held back by fixed mindsets and outdated processes.…